Lv1
22 积分 2022-11-10 加入
Temporal improvements in survival with persistent disparities in acute myeloid leukemia: a two-decade population-based analysis from the United States
18天前
已完结
Time to recovery from neutropenia in patients with newly diagnosed IDH-1 mutated acute myeloid leukemia receiving azacitidine and ivosidenib in the AGILE clinical trial
20天前
已完结
Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review
23天前
已完结
Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?
23天前
已完结
Targeting the Menin-KMT2A Axis in AML: Translating Molecular Insights into Therapeutic Success
25天前
已完结
Clinical pharmacokinetics and pharmacodynamics of ivosidenib in patients with advanced hematologic malignancies with an IDH1 mutation
1个月前
已完结
Combination Strategies with Menin Inhibitors for Acute Leukemia
1个月前
已完结
Targeting the Menin– KMT2A Interface: Medicinal Chemistry Rules Governing Reversible, Covalent, and Degrader Inhibitors
1个月前
已完结
Design, synthesis, and evaluation of Menin-targeting compounds for the treatment of acute Myelocytic leukemia (AML)
1个月前
已完结
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
1个月前
已完结
皖公网安备34019202002308
